Quorum Sensing in Staphylococcus aureus Infections

This is a curated page. Report corrections to Microbewiki.

Introduction to Staphylococcus aureus

Scanning electron micrograph (SEM) of Staphylococcus aureus bacteria from a vancomycin intermediate resistant culture (VISA). Micrograph taken by Janice Hardy Carr at the Center for Disease Control in 2001 CDC.

By Elizabeth Eder


Staphylococcus aureus is a gram-positive cocci-shaped bacterium that commonly colonizes human epithelia. Epithelial surfaces include the skin and respiratory tract, and in these areas S. aureus is considered a natural component of the human microbiome and does not serve as a benefit or detriment to its human host. First identified in 1880, S. aureus is a facultative anaerobe, meaning it generates ATP with or without oxygen. While S. aureus is not naturally pathogenic on epithelial surfaces, infections can occur in these areas and range from pimples and impetigo to pneumonia and meningitis. Pathogenicity can develop through the infection of S. aureus in the bloodstream, and these infections are of great medical relevance due to their prevalence and virulence. Infections can be community-acquired (CA) or hospital-acquired (HA), with the latter illustrating the challenge of sterility in healthcare settings.

Compounding the issue of infection is the bacteria’s ability to develop drug resistance, resulting in strains such as methicillin-resistant Staphylococcus aureus (MRSA). These strains have been of increasing concern in the medical field for their persistence in nosocomial infections and comprise the majority of S. aureus infections (Boucher). The frequency of S. aureus infections, and the frequency of those infections acquiring methicillin-resistance, is increasing in hospitals in the U.S. The CDC reported a 62% increase in S. aureus-related hospitalizations from 1999 to 2005, and suggested that MRSA be considered “a national priority for disease control.” Understanding the molecular mechanism of virulence is critical for addressing the issue of S. aureus and MRSA infections, because the resistance that S. aureus develops seriously limits antibiotic usefulness. Despite the advances in patient care, technology, and heath environment sterility, S. aureus infections continue to be an issue in U.S. hospitals and communities. One mechanism of S. aureus that is currently being studied for its potential contribution to pathogenicity is the quorum sensing (QS) system of communication.

Medical Relevance and MRSA

Scanning electron micrograph (SEM) of Staphylococcus aureus bacteria from a vancomycin intermediate resistant culture (VISA). Micrograph taken by Janice Hardy Carr at the Center for Disease Control in 2001 CDC.

Staphylococcus aureus can become pathogenic whether or not it develops antibiotic resistance, but cases where strains do become resistant are of great concern for the morbidity and mortality associated with them. The economic costs infections impose on hospitals are also serious and significant. S. aureus isolates that do begin to acquire antimicrobial drug resistance are usually resistant to methicillin and other beta-lactam drugs, but progress through a series of stages prior to complete resistance. Isolates are initially considered susceptible, and then progress to intermediate, and finally resistant.

MRSA infection leading to an abscess. Image taken by Gregory Mordan, M.D. provided by the Center for Disease Control CDC.

Staphylococcus aureus infections can be categorized into five main types: localized skin infection, diffuse skin infection, deep localized infections, toxinoses, and other infections. Localized skin infections can result in cutaneous or subcutaneous abscesses and possibly bacteremia. Bacteremia is the infection of bacteria in the blood, which is normally a sterile and bacteria-free environment. When bacteria such as S. aureus are found in the blood, intravenous antibiotics are used as treatment to prevent further spread from the blood into the heart endocardium or bone marrow. Diffuse skin infections include impetigo, which results in facial sores and blisters and is also treated with antibiotics. Deep localized infections include infection of bone and bone marrow, called osteomyelitis, as well as septic arthritis. Toxinoses include toxic shock syndrome and gastroenteritis, but are not necessarily caused by bacterial infection but by bacterial toxins. S. aureus produces toxins that can lead to toxinosis when ingested. The other infections S. aureus can cause include endocarditis, pneumonia, and other inflammatory responses.

Antibiotics used to treat MRSA are vancomycin, linezolid, teicoplanin, tigecycline, daptomycin, and telavancin. Vancomycin remains the most common, though different studies investigating each antibiotic have revealed pros and cons to each. The over-prescription and over-use of antibiotics has been controversial in aiding the progression of multiple species of bacteria towards antibiotic resistance, and as strains continually develop less susceptibility newer antibiotics with different antimicrobial targets are in demand. In healthcare settings infections by both S. aureus and MRSA have increased over 1999-2005 as reported by the CDC. S. aureus-related infections in the U.S. increased from 294,570 to 477,927 and of those totals the number of MRSA infections increased from 127,036 to 278,203. Resistance to ampicillin, cephalothin, and erythromycin also increased over that period of time.

Quorum Sensing System

QS system agr encodes gene products that ultimately promote further transcription of agr locus in a process called autoactivation. Image from Novick & Geisinger (2008). 3.

Quorum sensing (QS) is a kind of chemical communication between individual bacterium and groups of bacteria that is dependent on the surrounding environmental conditions, cell density, and other regulatory factors. This communication can influence bacterial behavior, benefitting the bacteria when collaboration produces a response to the environment. The quorum sensing system in Staphylococcus aureus occurs through the accessory gene regulator (agr). It is a complex molecular mechanism and though the pathway is elucidated, the response of QS itself is not well understood.

Agr functions to increase the expression of certain virulence factors secreted by S. aureus and decrease certain cell surface proteins. There is evidence that agr contributes to S. aureus pathogenicity in several infection types, including subcutaneous abscesses, endocarditis, and arthritis. On a molecular level, the agr locus contains promoters P2 and P3 that encodes transcripts for RNAII and RNAIII, respectively. The P2 and P3 operons code for different proteins that have individual roles in agr-sensing. P2 operon encodes the RNAII transcript that produces gene products agrB, agr D, agrC, and agrA. These four products comprise the actual signaling system. The P3 operon encodes the RNAIII transcript that produces only one gene product—a toxin called delta-hemolysin—but that increases transcription of several virulence factors. However, it has been noted that the agr system is not necessary for the expression of virulence factors like toxins. AgrD and AgrB work together to produce an auto-inducing peptide (AIP). AgrD encodes for pro-AIP and transmembrane protein AgrB processes the pro-AIP to AIP, transporting it to the external cellular space. AIP will continue to accumulate in the external environment beyond the cell membrane, eventually binding to AgrC, a kinase embedded within the membrane. The AgrC kinase phosphorylates regulator AgrA, which then is responsible for the autoinduction of the agr locus by binding to the P2 and P3 promoters and initiating the cycle again. The agr-sensing system is a circuit that is auto-activating.
The agr system is an important component of QS, and has its own accessory regulators that are identified but not well understood functionally. Regulators of agr affect expression in differing environments, and can either encourage or inhibit biofilm formation.

QS and Pathogenicity

Illustration of S. aureus colonization and biofilm formation, with quorum sensing between colonies leading to detachment and new growth. Image from Yarwood et al. (2003). 4.

Quorum sensing has been noted to control systems ranging from biofilm formation to antibiotic resistance to virulence factor secretion. All of these mechanisms are critical for the pathogenicity of S. aureus and MRSA in vivo. Biofilm formation is interestingly not considered a benefit to virulence, and QS via the agr system works to inhibit S. aureus biofilms. A biofilm is a grouping a cells together in an adherent colony, and is considered high cell density.

Infection Prevention and Treatment

Ball-and-stick model of RNAIII-Inhibiting Peptide (RIP), a QS inhibitor used to determine an analog able to prevent MRSA infections in vivo. Image from Kiran et al. (2008) 9.

Antibiotic therapy, when used properly and with caution, is effective in eliminating many types of S. aureus infections. MRSA infections, however, pose a greater challenge. Few antibiotics are currently effective in elimination of MRSA, and there have been cases of susceptible colonies (MSSA) evolving into resistant colonies (MRSA) within the host. Intermediate susceptibility has been reported for S. aureus strains in vancomycin as well (VISA). Vancomycin remains a stronghold for MRSA treatment, but in the future antibiotics under development include dalbavancin, oritavancin, ceftobiprole, and ceftaroline. Dalbavancin and oritavancin are in the class of lipoglycopeptides, while ceftobiprole and ceftaroline are cephalosporins.

As antibiotics continually seek to target different microbial components, an important target that is also under consideration in S. aureus and MRSA infections is the QS system. There is evidence of a potential drug target in the QS system that acts to disrupt the cell-to-cell communication and prevent virulence by inhibiting RNAIII. A natural product found in the bark of witch hazel trees, hamamelitannin, is an analog of RNAIII-inhibiting peptide (RIP).

References

[1] Boucher, HW and Corey, GR (2008) Epidemiology of methicillin-resistant Staphylococcus aureus. Clinical Infectious Diseases 46:344-349.
[2] Haddadin, AS, Fappiano, SA, Lipsett, PA (2002) Methicillin resistant Staphylococcus aureus (MRSA) in the intensive care unit. Postgrad Med J 78:385-392.
[3] Novick, RP and Geisinger, E (2008) Quorum sensing in Staphylococci. Annu Rev Genet 42:541-564.
[4] Yarwood, JM, Bartels, DJ, Volper, EM, Greenberg, EP (2004) Quorum sensing in Staphylococcus aureus biofilms. J Bacteriol 186:1838-1850.
[5] Periasamy, S, Joo, H, Duong, AC, Bach, TL, Tan, VY, Chatterjee, SS, Cheung, GY, Otto, M (2011) How Staphylococcus aureus biofilms develop their characteristic structure. PNAS 109:1281-1286.
[6] Rutherford, ST and Bassler, BL (2012) Bacterial quorum sensing: its role in virulence and possibilities for its control. Cold Spring Harb Perspect Med 2:a012427.
[7] Yarwood, JM, Schlievert, PM (2003) Quorum sensing in Staphylococcus infections. J. Clin. Invest. 112:1620-1625.
[8] Klein, E, Smith, DL, Laxminarayan, R (2007) Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999–2005. Emerg Infect Dis 13(12):1840-1846.
[9] Kiran, MD, Adikesavan, NV, Cirioni, O, Giacometti, A, Silvestri, C, Scalise, G, Ghiselli, R, Saba, V, Orlando, F, Shoham, M, Balaban, N (2008) Discovery of a quorum-sensing inhibitor of drug-resistant staphylococcal infections by structure-based virtual screening. Mol Pharmacol 73:1578-1586.

Authored for BIOL 291.00 Health Service and Biomedical Analysis, taught by Joan Slonczewski, 2016, Kenyon College.